Therapeutic Antibodies- exclusive 1-day masterclass in London, UK

LONDON - Oct. 22, 2014 - PRLog -- Antibodies are gaining a dominant role in the treatment of many life-threatening situations like cancer or autoimmune diseases due to their excellent safety/efficacy profile compared to other, conventional drugs. This masterclass will provide an introduction to therapeutic antibodies, pitfalls to be avoided in their development and strategies for their state-of-the-art design. In addition to the description of the current status new emerging developments and trends will be highlighted.

Key Benefits of attending:
• Understand the contextual backdrop to the therapeutic antibody industry
• Discuss the latest generation of antibodies and their features
• Learn from the advice offered and apply to your own projects

Who should attend:
Persons working for Biotech, Big Pharma, CMOs, Analytical Service Providers: Scientific staff in the fields of Discovery, Protein Engineering, Protein Analytics, Bioanalytics, Assay Development (Group+Lab Heads, Scientists of all levels), Ab-Project leader, Regulatory Managers, QA/QC.

For more information on the workshop or to register, please go to http://www.smi-online.co.uk/2014therapeutic-antibodies7.asp

Alternatively, contact Fateja Begum on tel: +44 (0) 20 7827 6184 or email: fbegum@smi-online.co.uk